What top creators are saying about Ionis Pharmaceuticals, Inc.(IONS)
A biotechnology company credited as a pioneer in RNA medicines.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Ionis Pharmaceuticals, Inc. in the last 30 days yet.
Top creators covering Ionis Pharmaceuticals, Inc. (IONS)
The 1 sources with the most insights about Ionis Pharmaceuticals, Inc. on Kazuha.
Latest insights about Ionis Pharmaceuticals, Inc. (IONS)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, February 16, 2026
Credited for its decades of foundational work that led to the success of RNA therapeutics, now considered a 'de-risked modality' and a 'mature platform'.
Monday, February 16, 2026
Credited for its decades of foundational work that led to the success of RNA therapeutics, now considered a 'de-risked modality' and a 'mature platform'.
Discussed alongside Ionis Pharmaceuticals, Inc. (IONS)
Other assets that creators frequently mention in the same content as Ionis Pharmaceuticals, Inc..
Frequently asked
Which podcasters and creators cover Ionis Pharmaceuticals, Inc. (IONS) the most?
The most active sources covering Ionis Pharmaceuticals, Inc. (IONS) on Kazuha are Andreessen Horowitz. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Ionis Pharmaceuticals, Inc. (IONS) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Ionis Pharmaceuticals, Inc. (IONS) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Ionis Pharmaceuticals, Inc. (IONS)?
Creators covering Ionis Pharmaceuticals, Inc. (IONS) most frequently also discuss PLTR, GSK, NVS, SDZ, PFE. See the "Discussed alongside" section above for full asset pages.